BioSpace News Archive

Medpace Holdings, Inc. announced that it will present at the following investor conference in September

Concept Medical Inc. (CMI) has been granted “Breakthrough Device Designation” from the U.S. Food and Drug Administration (FDA) for MagicTouch PTA (Percutaneous Transluminal Angioplasty), its Sirolimus drug coated balloon (DCB) catheter, for the treatment of Peripheral Artery Disease (PAD) in Below-the-Knee (BTK).

Novus Therapeutics, Inc. (NASDAQ: NVUS), a specialty pharmaceutical company focused on developing products for patients with disorders of the ear, nose, and throat (ENT), today announced financial results for the quarter ended June 30, 2019.

Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH), a global leader in musculoskeletal healthcare, will participate in the Wells Fargo Securities 2019 Healthcare Conference at the Westin Copley Place in Boston.

Electromed, Inc. announced that it will issue its financial results press release for the fiscal 2019 fourth quarter ended June 30, 2019 on Tuesday, August 27, 2019 after the close of the stock market.

Intends to Request Appeals Hearing and to Take Other Action to Maintain Listing

Gemini Bioproducts, LLC (“Gemini”), a portfolio company of BelHealth Investment Partners, LLC (“BelHealth”), a New York-based healthcare private equity firm, today announced a distribution agreement with Nordmark Biochemicals, a division of Nordmark Arzneimittel GmbH & Co. KG (“Nordmark”).

GateHouse Treatment and GH Recovery Solutions, New England’s premier providers of drug and alcohol treatment programs, today announced that Chad Clardy has joined the organization as Senior Vice President of Clinical Outreach

Medica today announced it will expand to North Dakota its cap on the maximum amount members in the state will pay for their insulin.

Ludi, Inc., a health care technology and physician-advocacy firm, announced today the hiring of Danielle O’Rourke as Chief Operating Officer (COO), a new position within the company.